导致高血压相关损伤的非血液动力学机制在脏的目标组件
Elisa Russo1, Elisabetta Bussalino2,3, Lucia Macciò2
1U.O.C. Nefrologia e Dialisi, Ospedale San Luca, 55100 Lucca, Italy.
International journal of molecular sciences
|June 10, 2023
概括
动脉高血压 (AH) 导致脏损伤,尽管有治疗方法. 新的研究揭示了分子途径和目标,以更好地管理高血压脏病.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 分子医学是分子医学.
背景情况:
- 动脉高血压 (AH) 是导致心血管疾病和死亡的全球主要原因.
- 甲状腺炎对病的发展和进展做出了重大贡献.
- 目前的治疗方法,包括RAAS抑制剂,草甘和内甲素受体对抗剂,无法完全解决AH诱导的损伤.
研究的目的:
- 审查AH诱导的损伤背后的分子机制.
- 确定高血压脏病的新型治疗点.
- 探索现有和新兴疗法如何保护脏.
主要方法:
- 对AH诱导的损伤分子机制的最近研究的综述.
- 分析涉及损伤的病理生理路径.
- 专注于将AH的分子后果与脏损伤联系起来的相互作用.
主要成果:
- 在AH诱导的损伤中的关键途径包括RAAS激活,免疫系统参与,氧化应激和炎症.
- 尿酸增加和细胞表型转变与AH的早期脏结构变化有关.
- 从了解这些分子通路中,新的治疗目标正在出现.
结论:
- 尽管有当前的治疗方法,但AH仍然是对脏健康的重大威胁.
- 了解RAAS激活,炎症和尿酸效应等分子途径至关重要.
- 针对这些新机制的新兴疗法为管理高血压病提供了未来的希望.
相关概念视频
Hypertension II: Pathophysiology
22
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
22
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
703
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
703
Hormonal Regulation
33.4K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.4K
Antihypertensive Drugs: Potassium-Sparing Diuretics
657
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
657
Acute Kidney Injury II: Pathophysiology
37
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
37


